Since single drug therapy of chronic lymphocytic leukemia (CLL) has not resulted in prolonged remissions of advanced disease, we initiated a program of combination chemotherapy, COP (cycloposphamide, vincristine sulfate, prednisone) for CLL patients with increasing adenopathy, splenomegaly, and/or s
In defence of the use of modern chemotherapy regimens for the treatment of patients with chronic lymphocytic leukaemia
โ Scribed by C. S. Tam; for the CLL-Australian Research Consortium
- Book ID
- 109003717
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 109 KB
- Volume
- 39
- Category
- Article
- ISSN
- 1444-0903
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Cutaneous presentation of B-cell chronic lymphocytic leukaemia (B-CLL) is uncommon, and the influence of skin changes on B-CLL prognosis is unclear. We report a patient with B-CLL Rai II, with multiple nodular skin infiltrations on the trunk, upper arms and thighs as well as constitutional symptoms,
## Abstract The role of leukapheresis was explored in the management of anaemia and thrombocytopenia complicating the accumulation of lymphoid cells in patients with chronic lymphocytic leukaemia and lymphoma. The aim of this study was to determine the efficiency of this procedure in correcting the